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http://dx.doi.org/10.1016/j.ccr.2013.06.003SUMMARYIkB proteins are the primary inhibitors of NF-kB. Here, we demonstrate that sumoylated and phosphorylated
IkBa accumulates in the nucleus of keratinocytes and interacts with histones H2A and H4 at the regulatory
region of HOX and IRX genes. Chromatin-bound IkBa modulates Polycomb recruitment and imparts their
competence to be activated by TNFa. Mutations in the Drosophila IkBa gene cactus enhance the homeotic
phenotype of Polycombmutants, which is not counteracted by mutations in dorsal/NF-kB. Oncogenic trans-
formation of keratinocytes results in cytoplasmic IkBa translocation associated with a massive activation of
Hox. Accumulation of cytoplasmic IkBa was found in squamous cell carcinoma (SCC) associated with IKK
activation and HOX upregulation.INTRODUCTION
NF-kB plays a crucial role in biological processes, such as
native and adaptive immune responses, organ development,
cell proliferation, apoptosis, or cancer (Naugler and Karin,
2008; Vallabhapurapu and Karin, 2009). NF-kB activation de-
pends on the IKK-mediated degradation of the NF-kB inhibitors,Significance
Up to now, the only known function for IkBa is as a repressor o
role in the chromatin through binding to histones H2A andH4 an
sion. Consistent with the functional relevance of polycomb
Drosophila development. In mammals, we found that IkBa reg
ciated with altered Hox/IRX expression.IkB proteins, that takes place in the cytoplasm and results in the
translocation of the NF-kB transcription factor to the nucleus,
where it activates gene expression. Recent studies demonstrate
the existence of alternative nuclear functions for regulatory ele-
ments of the pathway (reviewed in Espinosa et al., 2011), but
their biological implications remain poorly understood. Recently,
it has been demonstrated that nuclear IkBb binds the promoterf NF-kB. We now demonstrate that IkBa plays an alternative
d regulation of polycomb-dependent transcriptional repres-
-associated IkBa function, Cactus/IkBa deficiency affects
ulates keratinocyte differentiation and transformation asso-
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lation to prevent IkBa-mediated inactivation, thereby sustaining
cytokine expression in immune cells (Rao et al., 2010).
Numerous studies have reported nuclear translocation of IkBa
(Aguilera et al., 2004; Arenzana-Seisdedos et al., 1997; Huang
and Miyamoto, 2001; Wuerzberger-Davis et al., 2011) and
various partners for nuclear IkBa, including histone deacetylases
(HDACs) and nuclear corepressors, have been identified (Agui-
lera et al., 2004; Espinosa et al., 2003; Viatour et al., 2003). In
fibroblasts, nuclear IkBa associates with the promoter of Notch
target genes correlating with their transcriptional repression,
which is reverted by TNFa (Aguilera et al., 2004). Nevertheless,
themechanisms that regulate association of IkB to the chromatin
and its repressive function remain unknown.
IkBa-deficient mice die around day 5 because of skin inflam-
mation associated with high levels of IL1b and IFN-g in the
dermis, CD8+ T cells, and Gr-1+ neutrophils infiltrating the
epidermis, as well as altered keratinocyte differentiation (Beg
et al., 1995; Klement et al., 1996; Rebholz et al., 2007), similar
to keratinocyte-specific IkBa-deficient mice (IkBak5D/k5D) (Re-
bholz et al., 2007). In all cases, disruption of TNFa signaling
rescued the skin phenotype (Shih et al., 2009), suggesting that
lethality was associated with an excessive inflammatory
response, likely due to increased NF-kB activity. However,
mice expressing different IkBa mutants that are equally able
to repress NF-kB in the skin showed divergent phenotypes.
Specifically, mice expressing the nondegradable IkBa mutant,
IkBaS32-36A, developed skin tumors resembling SCC (van Hoger-
linden et al., 1999), whereas mice carrying a predominantly
nuclear form of IkBa show no overt skin defects (Wuerzberger-
Davis et al., 2011).
Skin differentiation depends on the correct establishment and
maintenance of specific gene expression patterns, including
genes of the HOX family, which in the basal progenitor cells
are repressed by EZH2, the catalytic subunit of the Polycomb
repressive complex 2 (PRC2) (Ezhkova et al., 2009, 2011).
PRC2 is composed by EZH2, the WD-repeat protein EED,
RbAp48, and the zinc-finger protein SUZ12 (Zhang and
Reinberg, 2001). Methylation of lysine 27 on histone H3
(H3K27me3) by EZH2 imposes gene silencing in part by trig-
gering recruitment of PRC1 (Cao et al., 2002; Min et al., 2003)
and histone deacetylases (HDACs). Here, we investigate anFigure 1. Phosphorylated and Sumoylated IkBa Is Found in the Nucleu
(A) Immunodetection of IkBa (green) in normal human skin and detail of basal layer
line indicates the dermis interphase. DAPI was used for nuclear staining.
(B) IF of IkBa in primary human keratinocytes.
(C) Subcellular fractionation of human keratinocytes followed by IB with the indic
(D) IkBa was immunoprecipitated from primary murine keratinocyte extracts follo
(E) IB analysis of His-tag precipitates from HEK293T cells transfected with the in
(F) HEK293T cells were transfected with the indicated IkBa plasmids and process
analyzed by IB.
(G) IF of IkBa and P-IKK in skin sections. Cells with P-IKK staining do not contai
(H) IB analysis of keratinocytes transduced with myc-IKKaEE or control.
(I) IF analysis of the indicated differentiation markers in skin sections of WT and
(J) IB analysis of indicated proteins in control or Ca2+-treated murine keratinocyt
(K) Determination of Filaggrin, K10, and p63mRNA levels in control and IkBa KD k
and compared to control cells. Error bars indicate SD. IkBa protein levels were
N, nuclear; C, cytoplasmic.
See also Figure S1.alternative function for IkBa in the regulation of skin homeosta-
sis, development, and cancer.
RESULTS
Phosphorylated and Sumoylated IkBa Localizes in the
Nucleus of Keratinocytes
To investigate the physiological role for nuclear IkBa, we per-
formed an initial screen to determine its subcellular distribution
in human tissues. We found that IkBa localizes in the cytoplasm
of most tissues and cell types as expected (Figure S1A available
online); yet, a distinctive nuclear staining of IkBa was found in
human (Figure 1A) and mouse skin sections (Figures 1A, S1A,
and S1C), more prominently in the keratin14+ basal layer kerati-
nocytes. IkBa distribution became more diffused in the supra-
basal layer of the skin and gradually disappeared in the more
differentiated cells. Specificity of nuclear IkBa staining was
confirmed using skin sections from newborn IkBa-knockout
(KO) mice (Figure S1B) and different anti-IkBa antibodies and
blocking peptides (Figure S1C). By immunofluorescence (IF)
and immunoblot (IB), we detected IkBa protein in both the cyto-
plasmic and the nuclear/chromatin fractions of human (Figures
1B and 1C) and mouse (Figure S1D) keratinocytes. Interestingly,
nuclear IkBa displayed a shift in its electrophoretic mobility
(z60 kDa) detected by different anti-IkBa antibodies, including
the anti-phospho-S32-36-IkBa antibody. We next precipitated
IkBa from nuclear and cytoplasmic keratinocyte extracts and
determined whether this low IkBa mobility was a result of ubiq-
uitin or SUMO modifications. We found that nuclear IkBa was
specifically recognized by anti-SUMO2/3, but not anti-SUMO1
or anti-ubiquitin antibodies (Figure 1D; data not shown). Here-
after, we will refer to this nuclear IkBa species as phospho-
SUMO-IkBa (PS-IkBa). By cotransfection of different SUMO
plasmids in HEK293T cells, we demonstrated that SUMO2 was
integrated to HA-IkBa at K21,22 (Figure S1E), independently of
S32,36 phosphorylation (Figure 1E). By subcellular fractionation,
we found thatmost HA-PS-IkBawas distributed in the nucleus of
HEK293T cells (data not shown), and both K21,22R and S32,36A
IkBa mutants showed reduced association with the chromatin
(Figure 1F). These results suggest that phosphorylation and
sumoylation are both required for IkBa nuclear functions in vivo.
Of note, PS-IkBa levels were always low in HEK293T cells whens of Normal Basal Keratinocytes
. B, basal; S, spinous, G, granular; and C, cornified layers of epidermis. Dashed
ated antibodies.
wed by IB with the indicated antibodies.
dicated plasmids. SUMO2 is incorporated in IkBa when K21,22 are present.
ed following the ChIP protocol to obtain the whole chromatin fraction that was
n nuclear IkBa.
IkBa KO newborn mice.
es. Total and nuclear/chromatin fractions are shown.
eratinocytes following Ca2+ treatment. Expression levels are relative to Gapdh
analyzed by IB. Data correspond to one representative of three experiments.
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Figure 2. IkBa Binds Histones H2A and H4
(A) PD experiment using GST-IkBa and native (lane 2) or denatured-renatured (lanes 3–4) human keratinocyte nuclear extracts. One representative gel stained
with Coomassie blue is shown (n = 3).
(B) Purification and analysis of B and C bands identified as histones H2A and H4 by mass spectrometry. Table indicates the number of peptides identified and
their score factor. The highest score is highlighted.
(C) Coprecipitation from DSP-crosslinked nuclear extracts from human keratinocytes.
(D and E) PD using different GST-H2A proteins and total lysates from HEK293T cells expressing the indicated proteins.
(legend continued on next page)
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and cell lysates directly obtained under denaturing conditions
(see inputs in Figures 1E and S1E).
It is well known that IKK activity regulates the cytoplasmic
levels of IkBa. By double staining of skin sections, we found
that the few cells that were positive for active IKK contained
IkBa, but this IkBa was excluded from the nucleus (Figure 1G).
To directly investigate whether IKK regulates subcellular distri-
bution of IkBa, we transduced primary murine keratinocytes
with lentiviral IKKaEE. We found that active IKKa induced a
decrease in the nuclear levels of PS-IkBa as determined by IB
(Figure 1H) and IF (Figure S1G). Additional experiments
comparing the effects of both IKK isoforms demonstrated that
IKKaEE was more efficient than IKKbEE in decreasing nuclear
PS-IkBa levels (60% ± 5% compared with 16% ± 9% reduction;
p < 0.001) (Figure S1F).
To directly address whether IkBawas required for normal skin
differentiation, we performed IF analysis using different markers
comparing IkBa wild-type (WT) and KO newborn skins. Consis-
tent with previous reports, IkBa-deficient mice do not show
any obvious skin defect at birth with a normal K5-positive basal
layer, although we observed a slight reduction in the thickness of
the K10-positive suprabasal epidermal layer. Most importantly,
IkBamutant skins showed a severe reduction of the more differ-
entiated layer of cells identified by the accumulation of filaggrin
granules (Figure 1I). This is a cause for impaired barrier function
(Palmer et al., 2006). Next, we aimed to distinguish between cell-
autonomous and non-cell-autonomous effects of IkBa defi-
ciency by using an in vitro system for keratinocyte differentiation
induced by high Ca2+ exposure (Hennings et al., 1980). In this
model, we found that keratinocyte differentiation was associated
with a decrease in both IkBa and PS-IkBa levels and activation of
nuclear IKK (Figures 1J and S1H). Notably, knockdown (KD) of
IkBa disturbs in vitro keratinocyte differentiation as indicated
by the impaired K10 and filaggrin induction in response to
Ca2+, which was accompanied by sustained expression of the
progenitor marker p63 (Figure 1K). Together, these results
strongly suggest that IkBa plays a cell-autonomous function in
skin differentiation.
IkBa Directly Binds to the N-Terminal Tail of Histones
H2A and H4
To further investigate the mechanisms underlying nuclear IkBa
functions, we searched for nuclear proteins that directly asso-
ciate with IkBa. Using GST-IkBa and human keratinocyte
nuclear extracts in pull-down (PD) experiments, we isolated pro-
teins of estimated molecular weights of 15 and 14 kDa that were
identified by mass spectrometry as histones H2A and H4 (Fig-
ures 2A and 2B). Interaction between histones H2A and H4(F) ClustalW alignment of the conserved KXXXK/R motifs in the N terminus of h
indicates the last AA included in GST-H2A 2-35.
(G) Histone peptide array hybridized with nuclear HEK293T extracts expressing
selected peptides are shown.
(H) Coprecipitation of cytoplasmic and nuclear HA-IkBa expressed in HEK293T
(I) HA-IkBa was precipitated using the indicated histone H2A peptide, the K/A m
renatured previous to the precipitation to disrupt preformed complexes.
(J) Model for binding of the histone H4 peptide (unmodified or modified) to cons
See also Figure S2.and IkBa was further confirmed by coprecipitation of endoge-
nous proteins from keratinocyte nuclear extracts. Of note, the
NF-kB subunit p65 was absent from nuclear IkBa precipitates
but coprecipitated in the cytoplasmic fraction (Figure 2C). By
PD assays, we determined the specificity of IkBa binding
compared to other IkB homologs (Figure 2D) and mapped the
IkBa-binding domain of histone H2A to be between amino acids
2 and 35 (Figure 2E). Preincubation of IkBa with p65 prevented
its association with histones (Figure S2A), suggestive of mutually
exclusive complexes.
Comparative sequence analysis of the IkBa-binding region of
histone H2A (AA1–36) and the homologous region of H4 revealed
the presence of a motif (3KXXXK/R) that was absent from other
histone and nonhistone proteins (Figure 2F). To further study
IkBa binding specificity, we screened a histone peptide array
using nuclear HA-IkBa expressed in HEK293T cells as bait. We
found that IkBa bound to peptides containing AA11–30 of his-
tone H4, but not the corresponding region of histone H3. Most
importantly, binding of IkBa to H4 was prevented by the combi-
nation K12/K16Ac and K20Ac or Me2 (Figure 2G). Because the
equivalent peptides from histone H2A were not included in the
array, we performed parallel precipitation experiments using
biotin-tagged peptides (AA5–23) of histone H2A and H4 (Figures
2H and 2I). We found that IkBa association was prevented by
K12Ac, K16Ac, and K20me2 of histone H4 or the equivalent
modifications of the H2A peptide (Figure 2H) and also when all
K/R residues in the 3KXXXKmotif were changed intoA (Figure 2I).
Of note that in these experiments histone-bound HA-IkBa was
mostly identified as a nonsumoylated band, which opens the
possibility that posttranslation modifications are not essential
to mediate this interaction in vitro. However, parallel binding
experiments using keratinocyte extracts, PS-IkBa, showed a
preferential binding to the histone peptides compared with the
cytoplasmic 37 kDa IkBa form (Figure S2B). Together, these re-
sults strongly suggest that only PS-IkBa can bind the chromatin,
but in HEK293T cells this molecule is then desumoylated in vivo
or as a consequence of the experimental processing.
To gain further insights into themolecular basis of IkBa binding
to histones, we completed the structure of IkBa obtained from
the Protein Data Bank (ID code 1IKN), which lacked part of the
ankyrin repeat (AR) 1, using RAPPER (Depristo et al., 2005)
and performed docking studies with AutoDock Vina (Trott and
Olson, 2010) of the histone H4 peptide, GKGGAKRHRKV, that
contains most of the KXXXK domain. Docking calculations
showed two deep pockets for K interaction in IkBa located
between ARs 1-2 and 2-3 and an additional shallower patch
between AR3 and 4. Overall, the peptide bound in a clearly nega-
tive region on the IkBa surface (Figure 2J), with higher affinity
than the modified peptide that was acetylated in the first andistones H2A and H4. Conserved K and R residues are in green. Red triangle
HA-IkBa. One informative area of the blot image and the relative binding of
cells with the indicated histone H2A and H4 peptides.
utant, or scrambled peptide. In (G), (H), and (I), cell lysates were denatured-
ecutive ankyrin repeats of IkBa (3KXXXK).
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Figure 3. Analysis and Identification of IkBa Target Genes
(A) Developmentally related genes selected from IkBa targets identified in ChIP-seq analysis. Fold change over the random background is indicated.
(B) Functional enrichment of target genes with p value cutoff%105 based on gene ontology (GO) as extracted from Ensembl database using GiTools. Enriched
categories are represented in heatmap with the indicated color-coded p value scale.
(legend continued on next page)
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that ARs of IkBa participate in histone binding because the
IkBaD55-106 mutant, lacking part of AR1, failed to bind GST-
H2A (Figure S2C). Similarly, this association was prevented by
1% deoxycholate (Figure S2D), as described for interactions
involving the ARs of IkBa (Baeuerle and Baltimore, 1988; Savi-
nova et al., 2009).
IkBa Is Specifically Recruited to the Regulatory Regions
of Developmental Genes
To identify putative PS-IkBa target genes, we performed
chromatin immunoprecipitation sequencing (ChIP-seq) using
chromatin extracts from primary human keratinocytes and anti-
IkBa antibody. We identified 2,778 enriched peaks, correspond-
ing to 2,433 Ensembl genes that were significantly enriched with
p values% 105. Gene ontology analysis showed that a signifi-
cant proportion of genes participate in biological processes
associated with embryonic development and cell differentiation.
IkBa targets included genes of theHOX and IRX families,ASCL4,
CDX2, NEUROD4, OLIG3, and NEURL, among others (Figures
3A and 3B). Annotation of the peak genomic positions to the
closest gene demonstrated that many peaks were positioned
immediately after the transcription start site (TSS), with a sharp
decrease near the transcription termination site (TTS) (Figure 3C),
whereas others were located far from promoter regions. Some of
the latter overlapped with regions enriched in H3K4me1, a his-
tone mark associated with enhancer regions (data not shown).
Randomly selected IkBa targets were confirmed by conventional
chromatin immunoprecipitation (ChIP) using primers flanking
the regions identified in the ChIP-seq experiment (Figure 3D).
Consistent with its overall effects on IkBa levels, sustained
Ca2+ treatment caused the loss of IkBa from all tested gene pro-
moters (Figure 3E). Similarly, short treatment with TNFa released
chromatin-bound IkBa in keratinocytes, as we previously found
in fibroblasts (Aguilera et al., 2004). However, we did not detect
a general effect of TNFa on PS-IkBa levels, but we consistently
found a partial redistribution of PS-IkBa to the soluble nuclear
fractions (Figure S3A). Next, we investigated whether TNFa
and Ca2+ modulatedHOX and IRX transcription in keratinocytes.
All tested IkBa targets (n = 12) were robustly induced by TNFa
treatment (up to 12-fold) following different kinetics (Figures
3F) and to a lesser extent (up to 3-fold) by Ca2+ treatment (Fig-
ure S3B) or IkBa KD (Figure S3C). Interestingly, 1 hr of TNFa
treatment prevented Ca2+-induced differentiation of murine
keratinocytes (Figure S3D), supporting the notion that PS-IkBa
integrates inflammatory signals with skin homeostasis (see Dis-
cussion). We also tested whether p65 participated in HOX or IRX
gene activation by TNFa. By ChIP analysis, we did not find any(C) Graphs show the relative distance to the nearest ChIPed region, 3 kb upstrea
(D) Validation of the identified DNA regions (222 to200 for HOXA10,9,380 to
and 18,820 to 18,800 for IRX3) by conventional ChIP. Amplification of 2 kb d
(E) ChIP analysis of IkBa after 20min of TNFa or 48 hr Ca2+ treatments. In (D) and (E
(IgG) (n = 2).
(F) Expression levels of IkBa target genes following TNFa treatment analyzed by
kinetics are indicated in red.
(G) ChIP-seq profiles of endogenous IkBa occupancy in three enriched loci (HOX
H3K27me3 (from the UW ENCODE Project) in keratinocytes. (D–F) Bars represe
See also Figure S3.recruitment of p65 to IkBa target genes after TNFa treatment,
in contrast to a canonical NF-kB target gene promoter (Fig-
ure S3E). However, we detected low amounts of p65 at HOX
genes under basal conditions that might contribute to gene
repression (Dong et al., 2008), although the function of
chromatin-bound p65 at regions distant from the TSS of both
NF-kB targets and nontargets is unresolved. Binding of p65 to
HOX and IRX was reduced after TNFa treatment, suggesting
that p65 was redistributed from noncanonical to canonical
NF-kB targets once activated.
Silencing ofHOX genes in keratinocytes involves PRC2 and its
core component the H3K27 methyltransferase EZH2 (Ezhkova
et al., 2009; Mejetta et al., 2011). To explore a putative associa-
tion between IkBa and PRC2 function, we crossed our list of
2,433 IkBa targets with available ChIP-seq data from keratino-
cytes. Approximately 50% of IkBa targets corresponded to
genes enriched for the H3K27me3 mark (Figures 3G and S3F),
although IkBa targeted only 13% of the H3K27 trimethylated
genes. Most importantly, genomic sequences occupied by
IkBa essentially overlapped with those regions containing high
H3K27me3 levels (Figure 3G).We also found a statistically signif-
icant overlap (p < 1016) between IkBa target genes and PRC tar-
gets in ES cells (Birney et al., 2007; Ku et al., 2008) (Figure S3G).
IkBa Interacts with and Regulates Association of PRC2
to Target Genes in Response to TNFa
In themass spectrometry analysis of proteins that associate with
GST-IkBa, we identified a few peptides corresponding to chro-
matin modifiers, such as EZH2 and SUZ12, and SIN3A (Figure
S4A). Specificity of IkBa interactions with PRC2 elements, but
also IkBa association to the PRC1 protein BMI1, was confirmed
by PD assays (Figure S4B). SUZ12 was able to interact with
nuclear IkBa, whereas p65 specifically associated with cyto-
plasmic IkBa in the IP experiments (Figure 4A). Importantly,
exogenous wild-type IkBa, but not an IkBa mutant that failed
to bind histones, facilitated the association of SUZ12 to GST-
H4 (Figure 4B). Moreover, ChIP experiments demonstrated
that TNFa treatment induced the dissociation of SUZ12 from
IkBa target regions, but not non-IkBa targets (Figure 4C).
Sequential ChIP experiments demonstrated that IkBa and
SUZ12 simultaneously bound to IkBa target genes (Figure 4D).
To test the functional relevance of IkBa in PRC-mediated
repression, we used WT murine embryonic fibroblast (MEFs),
which expressed detectable levels of PS-IkBa (Figure 4E) and
IkBa KO MEFs. By ChIP-on-chip experiments using three
different IkBa antibodies, we confirmed that several Hox genes
were also targets of IkBa in MEFs (Table S1). By ChIP, we found
that SUZ12 and EZH2 bound IkBa targets efficiently in WTMEFsm and downstream of the RefSeq gene’s TSS and TTS.
9,360 for HOXB2, +6,166 to +6,186 for HOXB5, +4,451 to +4,471 forHOXB3,
istant regions was used as negative controls.
), graphs represent mean enrichment relative to nonspecific immunoglobulin G
qRT-PCR. Gene represented is in black, whereas genes following the same
A, HOXB, and IRX5) and one negative locus (JARID1B/KDM5B) compared to
nt mean, and error bars indicate SD.
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Figure 4. IkBa Interacts with and Regulates Association of PRC2 in Response to TNFa
(A) IB analysis of IkBa precipitates from nuclear and cytoplasmic primary murine keratinocyte extracts. Five percent of the input and 25% of the IP was loaded in
all cases except for detection of IkBa input that represents 0.5%.
(B) PD using GST-H4 and cell lysates from HEK293T expressing different combinations of HA-IkBa and SUZ12.
(C) Relative recruitment assessed by ChIP of SUZ12 to different genes 40 min after TNFa in primary murine keratinocytes.
(legend continued on next page)
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TNFa treatment induced a significant but temporary release of
SUZ12 and EZH2 from these loci, which peaked after 30–
60 min of treatment (Figure 4F). The binding of PRC2 proteins
at Hox genes inversely correlated with the expression of
these Hox genes (Figure 4G). In contrast, IkBa KO cells failed
to activate Hox transcription in response to TNFa (Figure 4G),
which is consistent with a defective release of PRC2 proteins
(Figure 4F). Unexpectedly, we did not detect changes in
H3K27me3 levels in these Hox genes upon TNFa treatment at
any of the time points studied (20 min, 2 hr, and 7 hr) (data not
shown), likely reflecting the high stability of this histonemodifica-
tion (De Santa et al., 2007). Supporting the possibility that activa-
tion of IkBa targets is independent of the enzymatic activity of
EZH2, a 24 hr treatment with the EZH2 inhibitor DZNep does
not affect Hoxb8 or Irx3 messenger RNA (mRNA) levels in kera-
tinocytes (data not shown). Together, these results suggest that
transcriptional repression-activation of these genes does not
strictly depend on EZH2 enzymatic activity but rather PRC2
release might modulate the dissociation of PRC1 or HDACs
(van der Vlag and Otte, 1999) that associate with more dynamic
chromatin modifications. In agreement with this possibility, his-
tone H3 is rapidly acetylated following TNFa treatment at
different Hox gene promoters (Figure S4C).
To further study the involvement of NF-kB in the regulation of
IkBa targets by TNFa, we attempted to use different mutant
MEFs, including the p65, Ikka, Ikkb, and the triple p65;p50;c-
Rel KO. We found that TNFa induced Hox and Irx expression in
both p65 and Ikkb KO cells (Figure S4D) suggesting that it was
NF-kB independent. However, specific mutants contained vari-
able levels of IkBa and PS-IkBa (Figures S4E and S4F), which
make a more accurate quantitative analysis unproductive. Inter-
estingly, phosphorylation of nuclear IkBa was not reduced in the
Ikka or Ikkb KO cells (Figures S4F), indicating that other kinases
are involved in generating PS-IkBa. Only triple KO cells, which
essentially lacked IkBa (Figure S4G) and the Ikka-deficient
MEFs, showed a strong defect on Hox and Irx transcription
(Figures S4D and S4H). To better understand the contribution
of NF-kB to Hox regulation, we next performed luciferase re-
porter assays measuring the ability of different IkBamutant pro-
teins to repress a Hoxb8-promoter construct compared with a
reporter containing three consensus sites for NF-kB (3xkB).
We found that WT IkBa and the nuclear IkBaNES mutant (Huang
et al., 2000) significantly repressed both promoters. However,
mutations that affect chromatin-association (Figure 1F) pre-
vented Hoxb8 repression but still inhibited the expression of
the 3xkB reporter (Figure 4H). Consistently, Hoxb8mRNA levels
were significantly reduced in the skin of mice expressing IkBaNES(D) Sequential ChIP using the indicated combinations of antibodies. An analysis
(E) IB analysis of WT fibroblasts showing the presence of cytoplasmic and nucle
(F) Relative chromatin binding of PRC2 and IkBa in WT and IkBa KO MEFs treat
(G) Relative levels of the indicated genes in WT and IkBa KO MEFs.
(H) Luciferase assays to determine the effect of different IkBa constructs on the ac
levels of different constructs.
(I) Expression levels of HoxB8 in the skin of WT and IkBaNES/NES mice by qRT-PC
(J and K) Analysis of skin sections from 7- to 8-week-old WT and IkBaNES/NESmice
suprabasal marker K10, and filaggrin (K). Throughout the figure, bars represent m
See also Figure S4 and Table S1.(Wuerzberger-Davis et al., 2011) (Figure 4I). Moreover, these
animals showed an expansion of the K14-positive basal layer
of keratinocytes containing nuclear IkBa (Figure 4J), associated
with increased proliferation measured by ki67 staining and
impaired differentiation as indicated by the reduced thickness
of the suprabasal K10-expressing layer (Figure 4K).
Genetic Interaction between IkBa/cactus and polycomb
in Drosophila
Polycomb group (PcG) IkB and NF-kB proteins are conserved
from flies to humans. In addition, Drosophila contains one Hox
cluster, compared with four clusters in vertebrates, which facili-
tates studying genetic interactions. We first confirmed that the
single Drosophila IkB homolog, cactus (cact) (Geisler et al.,
1992), maintained the capacity to associate with histones
(Figure 5A). By IF, we detected colocalization of cactus and
Polycomb (Pc), a PRC1 protein that is essential for the repressive
PRC2 function, in specific bands of polytene chromosomes
(Figure 5B). Most of the cactus staining overlapped with Pc,
but only a few Pc-positive bands contained cactus. Based on
our mammalian data, our first attempt was to generate single
PRC2mutants and combine themwith cactus-deficientmutants.
All mutants were tested in heterozygosis because homozygous
mutations in cactus or PcG genes are lethal.
We found that heterozygous mutations in PRC2 genes (e.g.,
the null mutations of E(z)) as well as the composed E(z) and
cact exhibit no overt homeotic phenotypes. In contrast, hetero-
zygous Pc mutants exhibit a variety of characteristic homeotic
transformations, including the partial transformation of the sec-
ond and third (mesothoracic and metathoracic) legs toward first
(also known as prothoracic) legs that in males are characterized
by the presence of sex combs. Modifications of this phenotype
(also called ‘‘extra sex comb’’) have been extensively used as
a functional assay to validate new PcG proteins in vivo. Thus,
we tested the effect of reducing cact on Pc-induced homeotic
transformation using 12 recessive mutations of cact and two
independently generated Pc alleles. All cact mutant alleles, but
more prominently cact1, enhanced the ‘‘extra sex comb’’ pheno-
type of Pc mutations (Pc3 and PcXT109) (Figure 5C; Table S2).
Because cells lacking cact exhibit massive nuclear localization
of the transcription factor dorsal (dl, Drosophila NF-kB/Rel/p65
ortholog) during postembryonic stages (Lemaitre et al., 1995),
we tested whether enhancement of homeotic defect of Pc by
cact mutations is due to increased dorsal activity. Because sta-
bility of cact is under NF-kB/Dorsal control (Kubota and Gay,
1995), we anticipated that for phenotypes due to increased
dorsal, dl mutations would counteract cact mutations, whereas
for phenotypes independent of dorsal, reducing dl should yieldof two different Hox regulatory regions is shown.
ar IkBa.
ed with TNFa. ChIP values were normalized by IgG precipitation.
tivity of HoxB8 compared to the 3xkB reporter. Lower panels show expression
R (n = 2).
by IF. K14 labels the basal layer keratinocytes (J). Immunostaining of ki67, the
ean, and error bars indicate SD.
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Figure 5. Mutations in cactus/IkBa Enhances the Homeotic Phenotype of Heterozygous Pc Mutants in Drosophila melanogaster
(A) PD using GST-cactus and detection of p65 expressed in HEK293T or H2A from a histone-enriched extract.
(B) Representative image of a double IF for cact and Pc inDrosophila salivary polytene chromosomes. Selected region is shown in themagnification. cact-positive
bands always overlap Pc staining.
(C) The percent of mutant adults with ‘‘extra sex comb’’ in legs 2 and 3 (red circles) wasmeasured in at least 100 legs of flies heterozygous for 12 cactmutations in
two different Pc/+ mutant backgrounds.
(D) Representative image of the homeotic phenotype induced by cact in Pc mutants, which is enhanced by heterozygous mutation of dorsal. In (C) and (D), the
percentage of flies with ‘‘extra sex combs’’ in leg 2 is indicated.
(E) Frequency of the homeotic phenotypes corresponding to the number of ‘‘extra sex combs’’ in second and third leg in flies with the indicated cactus, dorsal, and
Polycomb mutations.
See also Tables S2 and S3.
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zygous dl mutations significantly enhanced the extra sex comb
transformation phenotype of Pc heterozygotes (Table S3),
similar to the effect of cact mutations. Furthermore, by gener-
ating triple heterozygous strains carrying the null allele of dorsal
(dl1), the PcXT109 allele and different cact alleles, we found that160 Cancer Cell 24, 151–166, August 12, 2013 ª2013 Elsevier Inc.most of the triple heterozygous cact;dl;Pc exhibited similar or
stronger homeotic phenotypes than double heterozygotes for
dl;Pc and cact;Pc of a particular allelic combination (Figures
5D and 5E). Note that the smaller number of animals scored
in the triple heterozygotes also reflects the higher lethality of
this genotype. These data support our finding that IkB/cactus
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IkBa Is a Modulator of Polycomb Functioncooperates with Polycomb-mediated repression, independently
of NF-kB/dorsal, which is relevant for the regulation of epidermal
development in the fly.
Requirement of IkBa for Keratinocyte Transformation
and HOX Upregulation
Deregulated HOX expression is a common trait in cancer
(De Souza Setubal Destro et al., 2010; Hassan et al., 2006;
Yamatoji et al., 2010; Zhai et al., 2007), including squamous
cell carcinoma (SCC). To study whether IkBa participates in
Hox deregulation of SCC, we induced transformation of pri-
mary murine keratinocytes by expressing mutant H-RasV12
plus DNp63a using retroviral infection (Keyes et al., 2011).
We found that PS-IkBa, which was consistently detected in
the nuclear fraction of control-transduced keratinocytes, was
mainly lost in transduced cells associated with P-IKK induc-
tion (Figure 6A). By ChIP assay, we found that binding of
SUZ12 and EZH2 at IkBa targets was significantly decreased
in these cells (Figure 6B), concomitant with a massive increase
in IkBa target gene expression (Figure 6C). Furthermore,
transformed keratinocytes growing in three-dimensional (3D)
matrigel cultures showed a complete cytoplasmic distribu-
tion of IkBa (Figure 6D), whereas IkBa KD abrogated the
capacity of transformed keratinocytes to grow in matrigel (Fig-
ure 6E), similar to the nontransformed cells. These results sug-
gest that accumulation of cytoplasmic IkBa favors oncogenic
transformation.
We further explored this possibility by analyzing the subcellu-
lar distribution of IkBa protein in a tissue microarray (TMA) that
included different human nonmalignant or premalignant skin
lesions (n = 21), skin cancer (n = 32), and normal control sam-
ples (n = 3). We detected nuclear IkBa in different nonmalig-
nant/noninflammatory lesions and normal skin samples. In
noninvasive tumors, such as actinic keratosis and Bowen’s
disease, a variable proportion of cells displayed localization of
IkBa in the cytoplasm, but most of them retained nuclear
IkBa, including chromosomal staining of the mitotic keratino-
cytes (Figure 6H). In more aggressive cutaneous SCC, around
50% of the tumor cells showed a complete loss of nuclear
IkBa and accumulation of cytoplasmic IkBa (Figures 6F and
6G). By qRT-PCR, we measured the mRNA levels of several
IkBa targets in 21 SCC and 13 normal skin samples. We found
that HOXD3 was significantly increased in human SCC com-
pared with normal skin (p = 0.04). We also detected a consistent
upregulation of HOXB9 and HOXB5 that did not reach statistical
significance due to the dispersion between samples (Figure 6I;
data not shown).
We extended our study to a cohort of 112 patients with uro-
genital SCC at different stages of tumor progression. We found
that cytoplasmic IkBa accumulation started before the stage of
tumor invasion, but total loss of nuclear IkBa was most pre-
dominant in the invasive areas of the tumors and in the metas-
tases. The significance of the correlations was p < 0.0001 for
normal adjacent versus in situ tumor, p < 0.0001 for in situ
compared with infiltrating tumors, and p = 0.3 when comparing
the tumor with the metastasis, using the Fisher’s exact test (Fig-
ures 6J and 6L). Cytoplasmic accumulation of IkBa significantly
associated with IKKa activation in these samples (Figures 6K
and 6L).DISCUSSION
Here, we show that IkBa plays a function in the chromatin asso-
ciated with repression of developmental genes, including the
HOX and IRX families. We focused our study on the skin kerati-
nocytes, where we found a significant accumulation of nuclear
IkBa; however, this mechanism is not exclusive of this cell type
and operates at least also in fibroblasts. In addition, we deci-
phered part of the mechanism of IkBa-mediated repression
that involves posttranslational IkBa modifications and associa-
tion with histones H2A/H4 and Polycomb proteins. The evolu-
tionary conservation of this mechanism is illustrated by the
strong homeotic phenotype of double Polycomb and cactus
mutants in Drosophila.
Compiled data on NF-kB signaling demonstrate that IkBa
plays a major role as inhibitor of the p65/p50 dimer and termina-
tion of NF-kB signal after stimulation. In the latter, establishment
of a nuclear IkBa-NF-kB transient ternary complex actively facil-
itates dissociation of NF-kB from specific binding sites in the
DNA (Zabel and Baeuerle, 1990), leading to the notion that
IkBa and chromatin binding are irreconcilable. Our experiments
demonstrate that a specific fraction of IkBa that is phosphory-
lated at S32,36 and posttranslationally modified by SUMO2 at
K21,22 is able to bind the histones. Sumoylation of IkBa had
been previously described, but the functional relevance of
this modification was mainly unknown (Desterro et al., 1998).
Although phosphorylation of S32,36 is the instructive mark that
targets IkBa for K21,22 ubiquitination and its subsequent degra-
dation by the proteasome, we now propose that K21,22 sumoy-
lation protects phosphorylated IkBa from degradation, thus
generating an unexpected functional IkBa species. Whether cal-
cium-induced degradation of PS-IkBa involves its desumoyla-
tion and subsequent ubiquitylation, and which modifications in
both IkBa and histones are imposed by TNFa and induce PS-
IkBa release from the chromatin, is currently under investigation.
Our data suggest that other IkB homologs cannot compensate
IkBa chromatin function because Hoxb5 and Hoxb8 failed to be
induced by TNFa in IkBa KO cells. However, expression of IkBb
from the IkBa locus compensates most of the defects of IkBa
deficiency (Cheng et al., 1998), which suggest that a specific
fraction of IkBb (i.e., hypophosphorylated nuclear IkBb) might
overlap nuclear IkBa functions in the skin or that ectopic IkBb
affects regulation of cytokines that mediate lethality in IkBa KO
models (Rebholz et al., 2007). It is the strong association
between inflammation and the skin phenotype that has impaired
distinguishing between cell-autonomous and non-cell-autono-
mous effects of IkBa deletion on keratinocyte differentiation.
Our data indicate that IkBa plays an essential role in this process,
as shown by the strong decrease in the number of Filaggrin-
expressing cells in the skin of IkBa KO newborn mice, which
results in a defective skin barrier that might explain the massive
inflammatory response observed in these animals after cytokine
exposure. Moreover, this function is cell autonomous as indi-
cated by our in vitro data. However, in transformed keratinocytes
and human SCC, IkBa is accumulated in the cytoplasm associ-
ated with tumor progression and increased HOX expression,
which is consistent with the tumorigenic phenotype of mice ex-
pressing the chromatin binding-defective IkBa super-repressor
mutant in the skin (Dajee et al., 2003; van Hogerlinden et al.,Cancer Cell 24, 151–166, August 12, 2013 ª2013 Elsevier Inc. 161
Figure 6. IkBa Accumulates in the Cytoplasm after Keratinocyte Transformation Associated with Hox Induction
(A) IB analysis of IkBa in the subcellular fractions of primary and H-Ras/DNp63a transformed keratinocytes.
(B) ChIP analysis of PRC2 recruitment on the indicated genes in control and transformed keratinocytes.
(C) Expression levels of the indicated genes relative to Gapdh.
(legend continued on next page)
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Figure 7. Model for Nuclear IkBa Function in Normal and Transformed Cells
In brief, sumoylated and phosphorylated IkBa binds the chromatin of noninduced and nontransformed cells to maintain gene repression, which is relieved after
cytokine induction or keratinocyte transformation. Release of IkBa from the chromatin is, at least in part, mediated by IKKa and results in PRC dissociation and
specific gene activation. These effects are maximized by stimuli that lead to tumorigenesis.
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IkBa Is a Modulator of Polycomb Function1999, 2004). We propose that accumulation of IkBa in the cyto-
plasm, or even in the nucleoplasm as it is observed after TNFa
exposure, contributes to gene activation by sequestering
nuclear repressors. In contrast, knockin mice carrying a nuclear
IkBa mutant do not show defective skin function or signs of
SCC, even in aged mice (data not shown). Although we cannot
exclude the involvement of NF-kB in the IkBa mutant pheno-
types, these reports and our data support the concept that
nuclear IkBa through Hox/Irx regulation might provide a platform
to integrate control of barrier integrity with cytokine response,
while preventing cell transformation.
On the other hand, extensive in silico analysis of the IkBa
target promoters failed to reveal any enrichment of specific
sequences that could mediate binding specificity, which is
coherent with the absence of known DNA elements that recog-
nize PRC2 in mammalian genes and is different from Drosophila
genes that contain PRE elements (Simon et al., 1993). Instead,
our data show that IkBa binds the chromatin in regions enriched
for H3K27me3, which is antagonized by specific combinations of
histone H2A/H4 modifications. Such H2A/H4 modifications are
involved in skin differentiation (Frye et al., 2007) and are known
to regulate chromatin structure (Kimura et al., 2002; Shogren-
Knaak et al., 2006; Suka et al., 2002), which could be connected
with the IkBa function described here.(D) IF of IkBa in the transformed keratinocytes growing in 3D cultures.
(E) Transformation capacity ofH-Ras/DNp63a transduced keratinocytes in contro
number of spheres from 5 3 103 cells after 5 days in culture (lower panel). Sixtee
(F and G) Analysis by immunohistochemistry of IkBa distribution in different hum
cytoplasmic (C) distribution in the analyzed samples.
(H) Chromosomal localization of IkBa in mitotic cells from Bowen’s disease sam
(I) Expression analysis of the indicated genes by qRT-PCR. Red line indicates the
was determined using Student’s t test analysis.
(J) IkBa distribution in control and different grades of tumor progression in a coll
(K) Correlation between subcellular distribution of IkBa and P-IKK levels in this gr
chi-square test.
(L) Representative images showing IkBa and P-IKK staining in different lesions fro
analysis. In (B), (C), (E), and (I), bars represent mean, and error bars indicate SD.Based on our results, we propose a model (Figure 7) in
which nuclear PS-IkBa negatively regulates transcription of
developmentally related genes in collaboration with Polycomb
proteins. Keratinocyte differentiation or TNFa treatment result
in the loss of chromatin-associated IkBa and Polycomb
release, associated with a moderate or temporary activation
of Hox and Irx transcription, respectively. Upon oncogenic
transformation, nuclear IkBa is lost, but it accumulates in the
cytoplasm, leading to a massive activation of Hox and Irx
genes, likely related with cytoplasmic retention of negative
regulators of gene transcription (Aguilera et al., 2004; Viatour
et al., 2003). Future studies will focus on establishing the exact
histone code that is recognized by IkBa and the elements
involved in its regulation, both in physiological and pathological
situations.
EXPERIMENTAL PROCEDURES
Tissue Samples
Human tissue samples were obtained from the archive of the Pathology
Department of the Hospital del Mar with the consent of Bank Tumor Commit-
tee, following Spanish Ethical regulations and guidelines of the Declaration of
Helsinki. Patient identity remained anonymous. Mouse samples were obtained
from pathogen-free mice colonies that included C57Bl6/J, CD1, IkBa-deficient
(Beg et al., 1995), and IkBaNES/NES mice (Wuerzberger-Davis et al., 2011). Thel or IkBaKD cells. Image of 3D cultures (upper panels) and graph represents the
n fields (20x) from two independent experiments were counted.
an skin lesions. (G) Table indicates the percent of nuclear (N), diffuse (N/C), or
ples, but not in SCC cells.
mean expression in normal and SCC samples. Significance of the differences
ection of 112 human urogenital SCC samples.
oup of patients. Statistical significance of the association was determined by a
m the same patient. In (C) and (E) ***p < 0.001, as determined by Student’s t test
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IkBa Is a Modulator of Polycomb FunctionAnimal Care Committee of Generalitat de Catalunya, USCD and University of
Wisconsin approved all procedures.
Cell Fractionation
Cells were lysed in 10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT,
and 0.05% NP40 at pH 7.9 for 10 min on ice and spun at 3,000 rpm. Superna-
tants were the cytoplasmic fraction. Pellets were lysed in 5 mM HEPES,
1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, and 26% glycerol at pH 7.9,
sonicated 5 s three times, left on ice 20 min, and then centrifuged 15 min at
13,000 rpm to recover the soluble nuclear fractions. Pellets included the non-
soluble chromatin-enriched fraction.
Coimmunoprecipitation Assay and Peptide Array
For precipitation of nuclear extracts, nuclei were either crosslinked with dithio-
bis succinimidyl propionate (DSP, Pierce) 15 min at room temperature and
then sonicated in a bioruptor (Diagenode) in 1% SDS-containing buffer and
then neutralized by 1% Triton X-100, or directly sonicated in RIPA buffer
plus protease inhibitor cocktail (Roche) and 10 mM N-ethyl maleimide. In
both cases, nuclear lysates were centrifuged at 13,000 rpm for 15 min and
then incubated with 5 mg of the indicated antibodies. Precipitates were
captured with 35 ml of protein A-sepharose, extensively washed, and analyzed
by IB. In most of the experiments, we used the Clean-Blot IP Detection Kit
instead of standard secondary antibodies, which is optimized for postimmuno-
precipitation IB.
Histone peptides were synthesized as biotinylated N-terminal and C-termi-
nal amides (Peptides and Elephants). Peptides were incubated overnight at
4C with the indicated cell extracts and precipitated with streptavidin-sephar-
ose beads (Amersham) for 45 min. Denatured HEK293T nuclear extracts were
used to hybridize a histone peptide array from Active Motif (N.13001). Peptide
composition can be found at http://www.activemotif.com/catalog/667/
histone-peptide-array and includes different combinations of acetylated,
methylated, or unmodified peptides.
Chromatin Immunoprecipitation, ChIP-on-Chip, and ChIP-Seq
Cells were subjected to chromatin immunoprecipitation (ChIP) as previously
described (Aguilera et al., 2004). Briefly, formaldehyde crosslinked cell ex-
tracts were sonicated, and chromatin fractions were incubated with sc-371,
sc-371G, sc-1643 (Santa Cruz Biotechnology), or 06-494 (Upstate) anti-IkBa
antibodies in RIPA buffer and precipitated with protein A/G-sepharose
(Amersham). Crosslinkage was reversed, and DNA was analyzed by PCR,
sequenced, or labeled to hybridize the Mouse BCBC PromoterChip 5 from
the University of Pennsylvania School of Medicine (http://www.cbil.upenn.
edu/EPConDB/). Data obtained were analyzed with AFM 4.0 software (Breitk-
reutz et al., 2001). Anti-IkBa antibody 06-494 (Upstate) was used for ChIP-seq,
and 6 ng of precipitated chromatin from human keratinocytes was directly
sequenced in these experiments. Data are deposited at the GEO database
with accession numbers GSM744581 and GSE24011. For mapping, peak call-
ing, and functional enrichment analysis, see the Supplemental Experimental
Procedures.
ACCESSION NUMBERS
The GEO accession number for the ChIP-on-chip and ChIP-seq reported in
this paper are GSM744581 and GSE24011, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.ccr.2013.06.003.
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